1. 1) Zinser, J. W. (1997). Tumor markers in cancer of the digestive system. Rev. Gastroenterol. Mex. 62 (3): 145–8.
2. 2) Ishiguro, T., Sugitachi, I., Sakaguchi, H. and Itani, S. (1985). Serum alpha-fetoprotein subfractions in patients with primary hepatoma or hepatic metastasis of gastric cancer. Cancer. 55 (1): 156–9. doi: 10.1002/1097-0142(19850101)55:1<156::aid-cncr2820550124>3.0.co;2-e
3. 3) Bourreille, J., Metayer, P., Sauger, F., Matray, F. and Fondimare, A. (1970). Existence of alpha feto protein during gastric-origin secondary cancer of the liver. Presse Med. 78(28):1277–1278.
4. 4) Augustin, G., Jelincic, Z., Tentor, D., Majerovic, M. and Matosevic, P. (2009). Hepatoid adenocarcinoma of the stomach: case report and short notes on immuno histochemical marker. Acta Gastro-Enterologica Belgica, Vol. LXXII.
5. 5) Chang, Y. C., Nagasue, N., Abe, S., Kohno, H., Kumar, D. D. and Nakamura, T. (1991). A Fetoprotein producing early gastric cancer with liver metastasis: report of three cases. Gut 32(5): 542-545. doi: 10.1136/gut.32.5.542